© 2011

Histone Deacetylases: the Biology and Clinical Implication

  • Tso-Pang Yao
  • Edward Seto

Part of the Handbook of Experimental Pharmacology book series (HEP, volume 206)

Table of contents

  1. Front Matter
    Pages i-xi
  2. Juliette Adjo Aka, Go-Woon Kim, Xiang-Jiao Yang
    Pages 1-12
  3. Astrid Hagelkruys, Anna Sawicka, Magdalena Rennmayr, Christian Seiser
    Pages 13-37
  4. Bryan J. Simmons, Todd J. Cohen, Richard Bedlack, Tso-Pang Yao
    Pages 79-101
  5. David B. Lombard, Daniel X. Tishkoff, Jianjun Bao
    Pages 163-188
  6. Debra Toiber, Carlos Sebastian, Raul Mostoslavsky
    Pages 189-224
  7. Sumit S. Mahajan, Vid Leko, Julian A. Simon, Antonio Bedalov
    Pages 241-255
  8. Back Matter
    Pages 257-260

About this book


The book highlights work from many different labs that taught us abnormal HDACs potentially contribute to the development or progression of many human diseases including immune dysfunctions, heart disease, cancer, memory impairment, aging, and metabolic disorders.


Acetyltransferase HDAC inhibitor Histone Deacetylase Lysine Acetylation Sirtuin

Editors and affiliations

  • Tso-Pang Yao
    • 1
  • Edward Seto
    • 2
  1. 1., Department of PharmacologyDuke UniversityDurhamUSA
  2. 2., Department of Molecular OncologyH.Lee Moffitt Cancer Center & Research ITampaUSA

Bibliographic information